BridgeMD
New treatment option for Breast Neoplasm Female
Official title The FYI on MRI: A Multilevel Decision Support Intervention for Screening Breast MRI
ClinicalTrials.gov ID: NCT06892275
What this study is testing
- What it's testing
- The purpose of this study is to test the impact of a multilevel decision support intervention on informed decisions about breast MRI among high-risk Black and Latina women. Participants (N=80) will be randomized to (1) enhanced usual care (risk assessment + referral to nurse practitioner) or (2) decision support (enhanced usual care + decision aid).
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 74, women only
You may be able to join if
- female
- aged 18-74 years
- self-identifying as Black and/or Latina
- no personal history of breast cancer
- English- or Spanish-speaking
You likely can't join if
- aged \<18 or ≥75
- pregnancy
See the full eligibility criteria
- female
- aged 18-74 years
- self-identifying as Black and/or Latina
- no personal history of breast cancer
- English- or Spanish-speaking
- having received a mammogram with normal results in the last 12 months
- ≥20% lifetime breast cancer risk per the NCI Breast Cancer Risk Assessment Tool (BCRAT)
- aged \<18 or ≥75
- pregnancy
The study team makes the final eligibility decision.
Where it's taking place
- Washington D.C., District of Columbia, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years to 74 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Washington D.C., District of Columbia, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.